Figure 5.
Frequency of EGFR, KRAS, and TP53 mutations with or without B7-H3 positivity in adenocarcinoma. There are significant differences of frequency in EGFR and KRAS mutations between B7-H3 positive and negative adenocarcinomas. *, p < 0.05.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.